Opportunity
Simpler Grants.gov #RFA-AI-27-004
NIAID Atopic Dermatitis Research Network Clinical Research Centers Grant Opportunity
Buyer
National Institutes of Health
Posted
November 18, 2025
Respond By
May 29, 2026
Identifier
RFA-AI-27-004
NAICS
541715
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is announcing a forecasted funding opportunity for clinical research centers in the Atopic Dermatitis Research Network (ADRN): - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Purpose: - Fund clinical research centers conducting interdisciplinary and translational research on skin immunology and defense mechanisms - Focus on differences between individuals with atopic dermatitis and healthy controls - Support pilot trials, observational studies, and junior investigator development - Funding Details: - Total anticipated funding: $4,520,000 - Expected number of awards: 4 - Funding instrument: Cooperative agreement (grant) - No cost sharing or matching required - Eligibility: - Open to educational institutions, government entities, nonprofits, businesses, tribal governments, and foreign institutions - Notable Requirements: - Emphasis on interdisciplinary research and fostering junior investigator independence - No specific OEMs or vendors; this is a research grant, not a product procurement
Description
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to continue support for the Atopic Dermatitis Research Network (ADRN) program. This program supports research centers across the United States conducting interdisciplinary and translational research to improve understanding of skin immunology and defense mechanisms, focusing on differences between individuals with atopic dermatitis and healthy controls. The program also supports single site pilot trials or observational studies and opportunities for junior investigators to build research backgrounds and foster independence. The funding instrument type is a cooperative agreement with no cost sharing or matching requirement.